| Phase 4 |
| NCT06930573 |
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular… |
HCC |
Recruiting |
| Phase 3 |
| NCT07446335 |
A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With… |
Advanced Esophageal Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT07540416 |
Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch |
Acute Ischemic Stroke |
Not Yet Recruiting |
| NCT07617870 |
Pro-urokinase for Extended-Window Posterior Circulation Stroke |
Acute Ischemic Stroke |
Not Yet Recruiting |
| Phase 2 |
| NCT05182944 |
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With… |
Esophageal Cancer |
Recruiting |
| NCT05286957 |
MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC |
NSCLC |
Recruiting |
| NCT03736863 |
A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of… |
Esophageal Cancer |
Recruiting |
| NCT05738434 |
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for… |
Esophageal Cancer by AJCC V8 Stage |
Recruiting |
| NCT06718205 |
Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous… |
Esophageal Cancer |
Recruiting |
| NCT06557161 |
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT… |
Acute Lymphoblastic Leukemia, Adult |
Recruiting |
| NCT06559345 |
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of… |
Acute Lymphoblastic Leukemia, Pediatric |
Recruiting |
| NCT06564493 |
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT… |
Acute Lymphoblastic Leukemia, Pediatric |
Recruiting |
| NCT06564545 |
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of… |
Acute Lymphoblastic Leukemia, Adult |
Recruiting |
| NCT07016724 |
Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT07104149 |
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer |
Female, Age ≥ 18 Years Old |
Recruiting |
| NCT07294664 |
PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line… |
Advanced Gastric Cancer |
Recruiting |
| NCT05231850 |
A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage… |
Colon Cancer |
Not Yet Recruiting |
| NCT05364489 |
Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin… |
Advanced Colorectal Cancer |
Not Yet Recruiting |
| NCT05841134 |
Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of… |
MSI-H Colorectal Cancer |
Not Yet Recruiting |
| NCT06439550 |
Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC |
HER2-positive Gastric Cancer |
Not Yet Recruiting |
| NCT06492317 |
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer |
HER2-positive Gastric Cancer |
Not Yet Recruiting |
| NCT06760520 |
Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal… |
Locally Advanced Rectal Cancer |
Not Yet Recruiting |
| NCT06901622 |
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for… |
Gallbladder Cancer and Extrahepatic Cholangiocarcinoma |
Enrolling by Invitation |
| NCT07085273 |
Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of… |
Gastric Cancer |
Not Yet Recruiting |
| NCT07128693 |
A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy… |
Esophageal Squamous Cell Carcinoma |
Not Yet Recruiting |